Published: 29 January, 2025 | Volume 9 - Issue 1 | Pages: 020-023
Figure 3:
Targeting complement in IC-MPGN. Iptacopan, a factor B inhibitor, specifically binds to factor B and efficiently blocks the alternative pathway [17].
Read Full Article HTML DOI: 10.29328/journal.jcn.1001147 Cite this Article Read Full Article PDF
HSPI: We're glad you're here. Please click "create a new Query" if you are a new visitor to our website and need further information from us.
If you are already a member of our network and need to keep track of any developments regarding a question you have already submitted, click "take me to my Query."